The Choice. V e r s a t i l i t y. S t r e n g t h. F l e x i b i l i t y. of surgeons for half a century

Similar documents
3 Infection Prevention Solutions

Redefining Infection Management. Proven Clinical Outcomes

Surgical Solutions Product Catalogue DEPEND ON HALYARD'S EXPERTISE TO HELP PREVENT INFECTIONS IN THE OR

tensile strength. Prolus elicits a minimal inflammatory reaction in the tissue, followed by gradual encapsulation of the suture by fibrous tissue.

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Supplementary Appendix

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

No-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program

SYMMETRY ANTIMICROBIAL FOAMING HANDWASH with 0.3% PCMX Technical Data

CAVICIDE1. Technical Bulletin

VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS

General Approach to Infectious Diseases

Antibiotic Prophylaxis Update

Plus Antibacterial Sutures Evidence Summary

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

PVA Sponge Products. Bacteriostatic PVA sponges

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

For quality & safety. Type Composition Coating Colour Tissue reaction Absorption Presentation

Other Beta - lactam Antibiotics

NHS Dumfries And Galloway. Surgical Prophylaxis Guidelines

METRIGUARD. Technical Bulletin

Interrupting The ECMO Circuit

SIVEXTRO (tedizolid phosphate) oral tablet ZYVOX (linezolid) oral suspension and tablet

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Multi-Drug Resistant Organisms (MDRO)

The CARI Guidelines Caring for Australians with Renal Impairment. 8. Prophylactic antibiotics for insertion of peritoneal dialysis catheter

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria

Post-operative surgical wound infection

Prophylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi

Introduction. n Ventricular catheter placement one of the most common neurosurgical procedures

Treatment of septic peritonitis

Author - Dr. Josie Traub-Dargatz

2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania

Pathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California,

Reducing Infections in Surgical Practice. Fred A Sweet, MD Rockford Spine Center Illinois, USA

Scottish Surveillance of Healthcare Infection Programme (SSHAIP) Health Protection Scotland SSI Surveillance Protocol 7th Edition 2017 Question &

Medline Micro-Kill and Medline Micro-Kill+ Hard-Surface Germicidal Wipes Now With and Without Alcohol!

Surgical prophylaxis for Gram +ve & Gram ve infection

Antimicrobial Stewardship. We cannot afford to go back

During the second half of the 19th century many operations were developed after anesthesia

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Two (II) Upon signature

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24

2017 Introduction to Infectious Diseases Clinical Seminar Saturday 30th September - Sunday 1st October 2017 Hotel Grand Chancellor Hobart, Tasmania

Cleaning and Disinfection Protocol Vegetative Bacteria

So Why All the Fuss About Hand Hygiene?

General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship

Zyvox. Zyvox (linezolid) Description

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Hyperlink to Guideline

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Patient Preparation. Surgical Team

Chapter Anaerobic infections (individual fields): prevention and treatment of postoperative infections

Problem: Hospital Acquired Infections

Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma

What s next in the antibiotic pipeline?

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Surgery And Cephalosporins: A Marriage Made In Heaven Or Time For Divorce?

Silicone delivery liner assists easy release of 3M TM Ioban TM 2 Antimicrobial Incise Drape onto the skin.

Prevention of Surgical Site Infections

FOR IMMEDIATE RELEASE Media Contact: Erin Terjesen

An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery

Pectus Excavatum (Funnel Chest) Dr Hasan Nugud Consultant Paediatric Surgeon

Epidemiology and Economics of Antibiotic Resistance

No Sacrifice of Pushability or Torquability = More Control

TITLE: Antibacterial Sutures for Wound Closure after Surgery: A Review of the Clinical Effectiveness and Long-Term Adverse Effects

Specialist Referral Service Willows Information Sheets. Rigid endoscopy

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Antimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood

Source: Portland State University Population Research Center (

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014

Mastitis and On-Farm Milk Cultures - A Field Study - Part 1

INFECTION PREVENTION SILVER ANTI-MICROBIAL TEXTILES

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

Scottish Medicines Consortium

Cefuroxime 1.5gm IV and Metronidazole 500mg IV. Metronidazole 500mg IV/Ampicillin-sulbactam e 3g/Ceftriaxone 2gm. +Metronidazole 500mg/Ertapenem 1gm

Clinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC

EcoHydra Antimicrobial Handwash. Product Overview. Physical Properties. Product Description. Regulatory Compliance. Key Features and Benefits

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

4/3/2012. Wound Closure for the ER / Urgent Care & Pitfalls in Wound Closure and Optimal Materials & Repair Techniques

99.999% KILLS UP TO. MICROBES to help prevent healthcare-associated Infections

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Department of Pharmacy Practice, N.E.T. Pharmacy College, Raichur , Karnataka, India

Top Ten Articles Infection Prevention and Control

Antimicrobial prophylaxis. Bs Lưu Hồ Thanh Lâm Bv Nhi Đồng 2

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Transcription:

The Choice of surgeons for half a century V e r s a t i l i t y S t r e n g t h F l e x i b i l i t y

S t o p b l e e d i n g f a s t w i t h t h r e e p r o v e n p e r f o r m e r s SURGICEL Absorbable Hemostats have been trusted for half a century to stop surgical bleeding. 1,2 Proven Safety Proprietary oxidized regenerated cellulose (ORC) technology 1 designed to ensure purity and consistency Plant-based product with minimal tissue reaction 3 Fully absorbable within 7-14 days 3 Proven Efficacy Fast hemostasis 1 Used in more hospitals than any other absorbable hemostat product 1 Choice & Convenience Available in 3 unique forms ideal for a broad range of specialties and procedures 3 Long shelf life at room temperature* 3 Ready to use out of the package Flexible and malleable, can be cut to size *SURGICEL Original Absorbable Hemostat and SURGICEL NU-KNIT Absorbable Hemostat have a 5-year shelf life; SURGICEL FIBRILLAR TM Absorbable Hemostat has a 3-year shelf life.

P r o v e n B a c t e r i c i d a l P r o p e r t i e s SURGICEL Absorbable Hemostat is the first and only absorbable hemostat that is proven bactericidal against a broad range of gram-positive and gram-negative organisms including various antibiotic-resistant bacteria (MRSA, VRE, PRSP and MRSE),4,5 Logarithmic Reduction of MRSA 4 1.00E+10 1.00E+9 1.00E+8 CFU/mL 1.00E+7 1.00E+6 1.00E+5 1.00E+4 1.00E+3 1.00E+2 1.00E+1 Control SURGICEL Original Absorbable Hemostat SURGICEL NU-KNIT Absorbable Hemostat SURGICEL FIBRILLAR TM Absorbable Hemostat In vivo animal studies have proven SURGICEL Absorbable Hemostat, in contrast to other hemostatic agents studied, does not enhance infection 6-9 50 0 0 6 12 18 24 Time (hours) 40 Surviving Populations 30 20 Control Absorbable Gelatin Sponge Collagen Hemostatic Agent SURGICEL Absorbable Hemostat 10 0 0 5 10 20 30 Days The experimental model: 140 guinea pigs were utilized to simulate the development of intra-abdominal abscess and/or peritonitis, which can occur in humans when a large blood clot becomes contaminated. Clinical significance of these animal or in vitro data has yet to be determined. Closing SURGICEL Absorbable Hemostat into a contaminated wound without drainage may lead to complications and should be avoided. Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), penicillinresistant Streptococcus pneumoniae (PRSP), methicillin-resistant Staphylococcus epidermidis (MRSE). CFU=Colony Forming Units

SURGICEL FIBRILLAR Absorbable Hemostat Versatility Thin layers enhance your ability to visualize and work on bleeding site Fibril material provides broad surface area coverage Optimal Adherence Soft, layered material conforms and melts in to bleeding tissue until you remove it 1 Larger surface area advances hemostasis action Ideal Conformability Lightweight layers and tufts peel off as much or as little as desired 10 Use it in any size, shape, or thickness as needed for your specific application 10 Well suited for use in craniotomy, laminectomy 3 and coronary artery bypass graft procedures to control bleeding on the anastomosis site

SURGICEL NU-KNIT Absorbable Hemostat Stronger Material Dense knit material provides high tensile strength in the presence of heavy bleeding 1 Thick weave designed to stay together during surgery; permits suturing Greater Coverage Area Large surface area provides maximal coverage Soft, pliable weave designed to hold a suture 3 and for placement on delicate tissue 11 Versatile Wrap it, suture it in place, even insert it through a trocar, for unsurpassed application control Ideal for use in trauma, laparoscopic surgery, and various procedures, including sternotomies and solid organ 11

SURGICEL ORIGINAL Absorbable Hemostat Excellent Hemostasis With Optimal Handling Proven record of safety and efficacy for a broad range of bleeding situations 1,3 Sheer weave allows visibility of the bleeding site Flexible texture conforms to irregular surfaces provides optimal conformability in a fabric 1 Surgical Conformability Compatible with electrocautery 3 Easily removed after hemostasis is achieved 3 Easily cut or folded for use in endoscopic procedures 1

c h o o s e The SURGICEL Hemostat that s right for your procedure. Three proven & trusted performers SURGICEL Absorbable Hemostats provide a unique combination of hemostatic effectiveness, absorbability, and bactericidal properties. 4,5 For use in a broad range of procedures 3 Neurosurgery Ortho-spine Cardiovascular Peripheral Vascular General Surgery Trauma Minimally Invasive Surgery Urology ENT Procedures The Choice of surgeons for half a century

Trusted by surgeons for half a century to stop bleeding fast. Proprietary ORC technology 1 Safe plant-based product 3 Bactericidal advantage 4-9 Size/Code Packaging SURGICEL FIBRILLAR TM Absorbable Hemostat 1 in x 2 in / 1961 10 eaches per box/case 2 in x 4 in / 1962 10 eaches per box/case 4 in x 4 in / 1963 10 eaches per box/case SURGICEL NU-KNIT Absorbable Hemostat 1 in x 1 in / 1940 24 eaches per box/case 1 in x 3.5 in / 1941 10 eaches per box/case 3 in x 4 in / 1943 24 eaches per box/case 6 in x 9 in / 1946 10 eaches per box/case SURGICEL Original Absorbable Hemostat 2 in x 14 in / 1951 24 eaches per box/case 4 in x 8 in / 1952 24 eaches per box/case 2 in x 3 in / 1953 24 eaches per box/case 0.5 in x 2 in / 1955 24 eaches per box/case References: 1. Data on file, Ethicon, Inc. 2. Hong Y, Loughlin K. The use of hemostatic agents and sealants in urology. J Urol. 2006;176:2367-2374. 3. SURGICEL Absorbable Hemostat. Full Prescribing Information, Ethicon, Inc. 4. Spangler D. Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect. 2003;4(3):255-262. 5. Data on file, in vivo study. Ethicion, Inc. 6. Dineen P. Antibacterial activity of oxidized regenerated cellulose. Surg Gynecol Obstet.1976;142:481-486. 7. Dineen P. The effect of oxidized regenerated cellulose on experimental intravascular infection. Surg. 1977;82:576-579. 8. Dineen P. The effect of oxidized regenerated cellulose on experimental infected splenotomies. J Surg Res. 1977; 23:114-116. 9. Kuchta N, Dineen P. Effects of absorbable hemostats on intra abdominal sepsis. Infect in Surg. 1983;2:441-444. 10. Amar A, Levy M. Applications of topical hemostatic agents in neurosurgery. Contemp Surg. 1996;4(6):1-3. 11. Mair H, Kaczemared I, Oberhoffer M, Groetzner J, Daebritz S, Reicharet B. Surgicel NuKnit hemostat for bleeding control of fragile sternum. J Thorac Cardiovasc Surg. 2005;130(2):605-606. To order: 1-800-255-2500 For technical support: 1-877-384-4266 www.surgicel.com Ethicon, Inc. Please see Essential Prescribing Information in pocket. 2009 Ethicon, Inc. DHMXXXX